Blood cancer Clinical Trials in Milwaukee, WI

As of September 2026, 59 paid clinical trials are recruiting for Blood cancer in Milwaukee, Wisconsin. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in Milwaukee

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

Prevention of Oral Mucositis in Adults in With Hematologic Malignancy

for Acute Leukemia

Sites in Milwaukee +2 more locations

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT07809984·Not Yet Recruiting·Listed Sep 9, 2026

60 clinical trials for Blood cancer

·Clear filters·

Email me when a new blood cancer trial opens in Milwaukee, WI.

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Sites in Milwaukee +38 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

for Multiple Myeloma

Sites in Milwaukee +27 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05201781·Phase 4·Recruiting·Listed Jan 2022

Apply to this trial

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for AML

Sites in Milwaukee +35 more locations

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT06001788·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

for Acute Leukemia

Sites in Milwaukee +21 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 2+

Code: NCT04811560·Phase 1, Phase 2·Recruiting·Listed Mar 2021

Apply to this trial

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for Relapsed Non-Hodgkin Lymphoma

Sites in Milwaukee +31 more locations

Sponsor: Lyell Immunopharma, Inc.

Sex: All·Age: 18+

Code: NCT05826535·Phase 1, Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Milwaukee, Madison +42 more locations

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT05735184·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for Cancer, Metastatic

Sites in Milwaukee +66 more locations

Sponsor: Massive Bio, Inc.

Sex: All·Age: All ages

Code: NCT03452774·Recruiting·Listed Mar 2018

Apply to this trial

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for AML

Sites in Milwaukee +25 more locations

Sponsor: TScan Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07702578·Phase 3·Recruiting·Listed Jul 2026

Apply to this trial

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for Lymphoma, Non-Hodgkin's

Drug: LY4584180

Sites in Milwaukee +20 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07226843·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

for Multiple Myeloma

Sites in Milwaukee, Madison +18 more locations

Sponsor: C4 Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07284758·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for Lymphoma, Non-Hodgkin

Sites in Milwaukee +22 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07101328·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

for Non-Hodgkin Lymphoma

Sites in Milwaukee +9 more locations

Sponsor: Imugene Limited

Sex: All·Age: 18+

Code: NCT03666000·Phase 1·Recruiting·Listed Sep 2018

Apply to this trial

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

for Myelofibrosis

Sites in Milwaukee +25 more locations

Sponsor: Disc Medicine, Inc

Sex: All·Age: 18+

Code: NCT05320198·Phase 1, Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for Myelodysplastic Syndromes

Drug: Venetoclax

Sites in Milwaukee +21 more locations

Sponsor: Taiho Oncology, Inc.

Sex: All·Age: 18+

Code: NCT04256317·Phase 2, Phase 3·Recruiting·Listed Feb 2020

Apply to this trial

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

for Chronic Lymphocytic Leukemia

Sites in Milwaukee +19 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06876649·Phase 4·Recruiting·Listed Mar 2025

Apply to this trial

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

for Chronic Lymphocytic Leukemia

Sites in Milwaukee +15 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06876662·Phase 4·Recruiting·Listed Mar 2025

Apply to this trial

Study of SGR-1505 in Mature B-Cell Neoplasms

for Mature B-Cell Neoplasm

Sites in Milwaukee +15 more locations

Sponsor: Schrödinger, Inc.

Sex: All·Age: 18+

Code: NCT05544019·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for AML

Sites in Milwaukee +20 more locations

Sponsor: TScan Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05473910·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

for B-cell Malignancy

Sites in Milwaukee +12 more locations

Sponsor: Carna Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT05602363·Phase 1·Recruiting·Listed Nov 2022

Apply to this trial

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

for Chronic Lymphocytic Leukemia

Drug: Sonrotoclax

Sites in Milwaukee +20 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07277231·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of BGB-11417 in Participants With Myeloid Malignancies

for Acute Myeloid Leukemia

Sites in Milwaukee +3 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT04771130·Phase 1, Phase 2·Recruiting·Listed Feb 2021

Apply to this trial

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

for Non Hodgkin Lymphoma

Sites in Milwaukee +10 more locations

Sponsor: Miltenyi Biomedicine GmbH

Sex: All·Age: 18+

Code: NCT06116110·Recruiting·Listed Nov 2023

Apply to this trial

A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting

for Follicular Lymphoma

1 location in Milwaukee

Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All·Age: 18+

Code: NCT06794268·Recruiting·Listed Jan 2025

Apply to this trial

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

for Acute Lymphoblastic Leukemia

Sites in Milwaukee, Wauwatosa +612 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 40 - 75·Accepts healthy volunteers

Code: NCT05334069·Recruiting·Listed Apr 2022

Apply to this trial

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for Lymphoma, Non-Hodgkin

Sites in Milwaukee, Wauwatosa +144 more locations

Sponsor: American Society of Clinical Oncology

Sex: All·Age: 12+

Code: NCT02693535·Phase 2·Recruiting·Listed Feb 2016

Apply to this trial

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for Acute Myeloid Leukemia

Sites in Milwaukee, Wauwatosa +324 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05564390·Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

for Mantle Cell Lymphoma

Sites in Milwaukee, New Berlin +225 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 60+

Code: NCT05976763·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Sites in Milwaukee, Madison +203 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT05554406·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Milwaukee, Sheboygan +211 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06317649·Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for Myelodysplastic Syndrome

Sites in Milwaukee, Madison +136 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06577441·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Milwaukee, Appleton +165 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT05554393·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Sites in Milwaukee, Sheboygan +127 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06672146·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for Hematopoietic and Lymphatic System Neoplasm

Sites in Milwaukee, Sheboygan +189 more locations

Sponsor: Children's Oncology Group

Sex: Female·Age: Up to 39

Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for Acute Myeloid Leukemia

Sites in Milwaukee, Madison +170 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 6 Months - 21

Code: NCT04293562·Phase 3·Recruiting·Listed Mar 2020

Apply to this trial

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements

Sites in Milwaukee, Menomonee Falls +80 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06649812·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for B Acute Lymphoblastic Leukemia

Sites in Milwaukee, Madison +185 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 25

Code: NCT03959085·Phase 3·Recruiting·Listed May 2019

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

Sites in Milwaukee, Madison +225 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting·Listed Mar 2015

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

Sites in Milwaukee, Madison +111 more locations

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting·Listed May 2011

Apply to this trial

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

for Non Hodgkin Lymphoma

1 location in Milwaukee

Sponsor: Medical College of Wisconsin

Sex: All·Age: 18 - 81

Code: NCT05990465·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors

for Hematopoietic and Lymphoid Cell Neoplasm

1 location in Milwaukee

Sponsor: Medical College of Wisconsin

Sex: All·Age: 18+

Code: NCT04892823·Recruiting·Listed May 2021

Apply to this trial

Top Research Study Locations in Milwaukee

Researchers run research studies in Milwaukee, WI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
Medical College of Wisconsin	Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Stroke	250
Aurora Sinai Medical Center	Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8	49
Aurora Saint Luke's Medical Center	Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma	47
Aurora Cancer Care-Milwaukee	Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma	45
Children's Hospital of Wisconsin	B Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Malignant Solid Neoplasm	44
Froedtert & the Medical College of Wisconsin	Multiple Myeloma, Pancreatic Cancer, Refractory Multiple Myeloma	25
Froedtert Hospital and the Medical College of Wisconsin	Central Nervous System Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL), Refractory Diffuse Large B Cell Lymphoma (DLBCL)	20
Children's Wisconsin	Abdominal Pain, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Refractory	20
Froedtert Hospital & the Medical College of Wisconsin	Breast Cancer, Pancreas Cancer, Acute Myeloid Leukemia (AML)	19
Aurora St. Luke's Medical Center	Pulmonary Hypertension, AV Block, Acute Decompensated Heart Failure	17
Froedtert Hospital	Aortic Stenosis, Bladder Cancer, Breast Cancer	14
The Medical College of Wisconsin	Abdominal Wound Dehiscence, Acute Kidney Injury, Anal Fistula	13
Froedtert & Medical College of Wisconsin	Cystic Fibrosis (CF), AML, Acute Myeloid Leukemia	10
Ascension Columbia Saint Mary's Hospital-Milwaukee Campus	Ampulla of Vater Carcinoma, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8	9
Marquette University	Aging, Stroke, Aerobic Exercise	8
Zablocki Veterans Administration Medical Center	Malignant Solid Neoplasm, Stage IVA Prostate Cancer AJCC v8, Acute Lymphoblastic Leukemia	8
Froedtert and The Medical College of Wisconsin	Advanced Renal Cell Carcinoma (aRCC), Aggressive Variant Prostate Carcinoma, Antibody-Mediated Rejection (AMR)	7
Ascension Columbia Saint Mary's Hospital - Milwaukee	Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Pancreatic Adenocarcinoma	5
Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee	Ampulla of Vater Carcinoma, Appendix Carcinoma, Carcinoma of Unknown Primary With Gastrointestinal Profile	4
Aurora St Luke's Medical Center	AMI, Cancer, Cutaneous Melanoma, Stage II	4
Clement J. Zablocki VA Medical Center, Milwaukee, WI	Atherosclerosis, De Novo Prostate Cancer, Lung Neoplasm	4
Medical College of Wisconsin/Children's Hospital of Wisconsin	Primary Immune Deficiency Disorder, Adenovirus, Covid19	4
Advocate Aurora Research Institute	Cardiovascular Diseases, Functional Mitral Regurgitation, Heart Diseases	3
Ascension Columbia St. Mary's	Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis	3
Ascension Saint Francis Hospital	Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8	3

Active & Upcoming Studies in Milwaukee (2026)

Recruiting trials in Milwaukee grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Common conditions studied in Milwaukee

Acute Myeloid Leukemia (15 active studies)
Breast Cancer (15 active studies)
Heart Failure (13 active studies)
Chronic Lymphocytic Leukemia (10 active studies)
Follicular Lymphoma (10 active studies)
Prostate Cancer (10 active studies)

Leading research sponsors in Milwaukee

Medical College of Wisconsin
National Cancer Institute (NCI)
AstraZeneca
Alliance for Clinical Trials in Oncology
Children's Oncology Group

Frequently asked questions

How many paid clinical trials are currently recruiting in Milwaukee?

There are approximately 675 recruiting clinical trials in Milwaukee, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Milwaukee pay participants?

Most recruiting trials in Milwaukee compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Milwaukee?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Milwaukee?

The most common conditions under active study in Milwaukee include Acute Myeloid Leukemia (15), Breast Cancer (15), Heart Failure (13), Chronic Lymphocytic Leukemia (10), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Milwaukee?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Milwaukee on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Milwaukee?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Milwaukee?

Recruiting research sites in Milwaukee include Medical College of Wisconsin, Aurora Sinai Medical Center, Aurora Saint Luke's Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Milwaukee right now?

The largest active categories in Milwaukee are Cancer & tumors (267), Cardiovascular (49), Neurology & pain (36). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Other cities in Wisconsin

Madison, WI(558)Green Bay, WI(112)Marshfield, WI(99)La Crosse, WI(93)Stevens Point, WI(85)Eau Claire, WI(84)Weston, WI(74)Sheboygan, WI(73)Ashland, WI(65)Wauwatosa, WI(63)Kenosha, WI(62)Appleton, WI(61)Oshkosh, WI(57)Wausau, WI(57)Rice Lake, WI(56)Minocqua, WI(55)Sturgeon Bay, WI(55)Racine, WI(51)Grafton, WI(49)New Richmond, WI(49)Summit, WI(48)West Allis, WI(48)Burlington, WI(47)Germantown, WI(47)Marinette, WI(47)Two Rivers, WI(46)Waukesha, WI(46)Oconto Falls, WI(45)Wisconsin Rapids, WI(43)Antigo, WI(39)Cudahy, WI(39)Menomonee Falls, WI(37)Oconomowoc, WI(37)West Bend, WI(37)Mukwonago, WI(35)Oak Creek, WI(35)Rhinelander, WI(35)Spooner, WI(29)Superior, WI(29)Medford, WI(27)Hayward, WI(25)Janesville, WI(20)Neenah, WI(20)Mequon, WI(19)New Berlin, WI(19)Brookfield, WI(16)Franklin, WI(16)Chippewa Falls, WI(15)Johnson Creek, WI(15)Chilton, WI(14)Greenfield, WI(14)Shawano, WI(13)Waupaca, WI(13)Ladysmith, WI(11)Berlin, WI(10)New London, WI(10)Fond du Lac, WI(9)Neillsville, WI(6)Glendale, WI(2)Hudson, WI(2)

Related healthcare resources in Wisconsin

Latest Milwaukee, WI clinical trials research report

Trials by condition in Milwaukee

Acute Myeloid Leukemia· 15 Breast Cancer· 15 Heart Failure· 13 Follicular Lymphoma· 10 Prostate Cancer· 10 Multiple Myeloma· 9 Stroke· 9

Conditions in Blood cancer (Milwaukee, WI)

Acute myeloid leukemia (AML)· 19 Non-Hodgkin lymphoma· 16 Multiple myeloma· 11 Hematologic malignancy· 11 Chronic lymphocytic leukemia (CLL)· 10 Follicular lymphoma· 10 Leukemia (other)· 9 Myelodysplastic syndromes (MDS)· 9 Diffuse large B-cell lymphoma (DLBCL)· 8 Mantle cell lymphoma· 6 Burkitt lymphoma· 5 Myeloproliferative neoplasm· 4 Marginal zone lymphoma· 4 Acute lymphoblastic leukemia· 3 Hodgkin lymphoma· 3 Small lymphocytic lymphoma· 3 Myelofibrosis· 2 Chronic myelomonocytic leukemia· 1

Blood cancer Clinical Trials in Milwaukee, WI

Newly added in Milwaukee

60 clinical trials for Blood cancer

Top Research Study Locations in Milwaukee

Active & Upcoming Studies in Milwaukee (2026)

Cancer & tumors (267 active studies)

Cardiovascular (49 active studies)

Neurology & pain (36 active studies)

Diabetes & metabolic (20 active studies)

Pediatric (11 active studies)

Mental health & behavior (5 active studies)

HIV / STI (3 active studies)

Vaccines (1 active study)

Common conditions studied in Milwaukee

Leading research sponsors in Milwaukee

Frequently asked questions

How many paid clinical trials are currently recruiting in Milwaukee?

Do clinical trials in Milwaukee pay participants?

Who can participate in a clinical trial in Milwaukee?

What conditions are most commonly studied in Milwaukee?

Are there clinical trials for healthy volunteers in Milwaukee?

How do I enroll in a clinical trial in Milwaukee?

Where can I take part in paid clinical trials in Milwaukee?

What kinds of studies are recruiting in Milwaukee right now?

Browse more clinical trials

Other cities in Wisconsin

Related healthcare resources in Wisconsin

Trials by condition in Milwaukee

Conditions in Blood cancer (Milwaukee, WI)